🇺🇸
United States · US · US:58468-0040_9b786f81-f4d8-4bc6-8f5f-68adbbfb60d1
Fabrazyme
UNIISPLATC A16AB04
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerGenzyme Corporation
CountryUS (United States)
ATC codeA16AB04
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1158468004011 VIAL, GLASS in 1 CARTON (58468-0040-1) / 7 mL in 1 VIAL, GLASS
Annotations
UNII (FDA Substance ID)
RZD65TSM9U
AGALSIDASE BETA
RxCUI 338817
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "RZD65TSM9U",
"rxcui": "338817",
"inchikey": null,
"display_name": "AGALSIDASE BETA",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"988513ab-b06f-4dd0-93f7-d2d4531dcce4": {
"match": "brand_token",
"title": "FABRAZYME (AGALSIDASE BETA) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GENZYME CORPORATION]",
"spl_version": "35",
"published_date": "2025-08-25"
}
},
"productid": "58468-0040_9b786f81-f4d8-4bc6-8f5f-68adbbfb60d1",
"productndc": "58468-0040",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "AGALSIDASE BETA",
"proprietary_name": "Fabrazyme",
"active_ingred_unit": "mg/mL",
"application_number": "BLA103979",
"marketing_category": "BLA",
"nonproprietary_name": "AGALSIDASE BETA",
"start_marketing_date": "20081217",
"active_numerator_strength": "5"
}Related drugs
Other records sharing ATC code A16AB04.
Access this data programmatically
Query Fabrazyme and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.